Building on Strong Scientific Foundations
OSSIANIX is a privately held company with a proprietary brain shuttle platform allowing brain specific delivery of biotherapeutics across the Blood-Brain Barrier. The company headquarters are in the University City Science Center in downtown Philadelphia and have research laboratories at the Stevenage Bioscience Catalyst in Stevenage, Hertfordshire, UK. Ossianix was founded by Frank S. Walsh, Corey Goodman and J. Lynn Rutkowski who have had distinguished careers in Academia, Pharma and Biotech and bring a wealth of experience to the development of the next generation of Biologics. The company started operations in 2012 with funding from Lundbeck Pharmaceuticals, BioAdvance and the ALS Association.
Following the Science
Board of Directors
Experience and Skill
Disclaimer
All Rights Reserved | Ossianix